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Acute pancreatitis (AP) is a leading cause of hospitalization among non-
malignant gastrointestinal disorders. The mortality of severe AP can reach
30–50%,which ismost probably owing to the lack of specific treatment. There-
fore, AP is a major healthcare problem, which urges researchers to identify
novel drug targets. Studies from the last decades highlighted that the toxic cel-
lular Ca2þ overload andmitochondrial damage are key pathogenic steps in the
disease development affecting both acinar and ductal cell functions.Moreover,
recent observations showed that modifying the cellular Ca2þ signalling might
be beneficial in AP. The inhibition of Ca2þ release from the endoplasmic reti-
culum or the activity of plasmamembrane Ca2þ influx channels decreased the
severity of AP in experimental models. Similarly, inhibition of mitochondrial
permeability transition pore (MPTP) opening also seems to improve the
outcome of AP in in vivo animal models. At the moment MPTP blockers are
under detailed clinical investigation to test whether interventions in MPTP
openings and/or Ca2þ homeostasis of the cells can be specific targets in
prevention or treatment of cell damage in AP.
This article is part of the themed issue ‘Evolution brings Ca2þ and ATP
together to control life and death’.1. Ca2þ is controlling secretory events in pancreatic acinar
and ductal cells
Intracellular Ca2þ signalling plays central role in the regulation of the secretory
processes of the exocrine pancreas. It is awell-known fact that in the exocrine pan-
creas acinar cells secrete digestive enzymes and pancreatic ductal epithelial cells
secrete HCO3 rich alkaline fluid that washes the digestive enzymes out from the
pancreas. The prompt coordination of the secretory events of the two cell types
is essential and Ca2þ has a central role in both pancreatic physiology and patho-
physiology. Recent studies suggest that these two cell types cannot be handled
separately since they are more likely integrated into a functional unit [1]. This is
further amplified by the neurohormonal regulation of exocrine pancreatic
secretion. It has been demonstrated that acetylcholine (the main stimulatory neu-
rotransmitter of the pancreas) is released from the parasympathic nerve endings,
releasing digestive enzymes from the acinar cells [2], whereas at the same time
enhances the pancreatic ductal fluid and HCO 3 secretion via M3 metabotropic
cholinerg receptor (M3R) mediated Ca
2þ release [3]. In addition, the circulating
hormone cholecystokinin (CCK) regulates pancreatic secretion via oscillatory
Ca2þ signals [4]. In pancreatic ductal epithelial cells (PDECs), the role of CCK
stimulation differs between species, in humans it has negligible direct effects,
but remarkably potentiates the stimulatory effect of secretin on the HCO 3
secretion [5]. The proper control of secretion is further potentiated by the strong
synergy between Ca2þ and cAMP signalling [6]. The physiological roles of
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Figure 1. Hypothetical sequence of events in the pathogenesis of AP. Pancreatitis inducing toxic stress factors can release the intracellular Ca2þ from the stores, such
as the endoplasmic reticulum (ER), or acidic organelles. However, the constant presence of toxins will lead to the elongation of the Ca2þ signals via multiple
mechanisms. First, the ER Ca2þ depletion activates the influx of extracellular (EC) Ca2þ. Second, the direct mitochondrial toxicity of the stress factors (such as
bile acids or non-oxidative ethanol metabolites), increases reactive oxygen species production and the sustained Ca2þ increase will lead to the opening of the
MPTP that will damage the mitochondria. The lack of intracellular ATP impairs the function of Ca2þ extrusion and reuptake pumps such as PMCA or SERCA.
These changes together will generate a vicious cycle leading to inhibited secretion and intracellular activation of digestive enzymes in acinar cells and impaired
ductal fluid and HCO 3 secretion. Altogether, these changes will trigger cell necrosis and AP.
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more detail in excellent reviews [7–10].2. The price of versatility: Ca2þ toxicity in acute
pancreatitis
Although it iswell established that physiologicalCa2þ signalling
controls the normal pancreatic functions on multiple levels,
it is also well documented that uncontrolled cellular Ca2þ over-
load leads to cellular damage and pathogenesis of acute
pancreatitis (AP; figure 1). In this chapter, we will summarize
the effects of the common stress factors that cause AP.
(a) Bile acids
Biliary pancreatitis is one of the most common forms of AP,
although the exact pathogenesis is not known in detail. One
possible explanation is the ‘common channel’ theory, which
suggests that an impacted gallstone creates communication
behind the stone connecting the common bile duct to the pan-
creatic duct. This would theoretically allow bile acids (BAs) to
reach the pancreatic ductal lumen or even the acinar cells [11].
However, this hypothesis was questioned by several studies
suggesting that instead of the reflux mechanism, increased
luminal pressure would cause the pancreatic damage [12–15].
Whether or not BAs reach the pancreatic tissue directly from
the luminal side, several observations suggest that BA reaching
the ductals cells from either basolateral or luminal sides can
trigger multiple cellular responses in acinar and ductal cells
that might contribute to the development of AP.
Earlier, our group showed that the hydrophobic, non-con-
jugated BA, chenodeoxycholate (CDCA) dose-dependently
affects HCO 3 secretion of pancreatic ductal epithelia [16].
We found that lower concentration of CDCA (100 mM) stimu-
lated and high concentration (1 mM) severely inhibited theion transport activities including the ductal HCO 3 secretion.
The explanation for this dual effect might be the type of Ca2þ
signals triggered by CDCA. Luminal administration of
100 mM CDCA evoked short oscillatory Ca2þ signals, which
were fully abolished by IP3 receptor inhibition. On the
other hand, challenging the pancreatic ductal cells with
1 mM CDCA caused a sustained Ca2þ elevation [16] and
severe damage of the mitochondrial morphology and
function [17]. Interestingly, in our hands N,N0-[1,2-ethane-
diylbis(oxy-2,1-phenylene)]bis[N-[2-[(acetyloxy)methoxy]-2-
oxoethyl]]-,bis[(acetyloxy)methyl]ester (BAPTA-AM) failed
to prevent the mitochondrial damage and therefore the inhibi-
tory effect of CDCA on the HCO 3 secretion [16], which might
be explained by the existence of a Ca2þ-independent direct
mitochondrial toxicity of bile acids [18]. Similarly to ductal
cells, pancreatic acinar cells respond with intracellular Ca2þ
elevation to BA challenge [19] due to IP3R and ryanodine
receptor activation. It is also well documented that taurolitho-
cholicacid 3-sulfate diminishs cellular ATP production [20] and
dissipate the mitochondrial membrane potential (DCm), which
was not affected by BAPTA-AM treatment [21]. Although BA
directly affects the acinar cells, the observations of Perides
et al. actually suggest that biliary pancreatitis is a receptor
mediated disease [22]. They showed that the G-protein-
coupled cell surface bile acid receptor (Gpbar1, or TGR5) is
expressed at the apical membrane of pancreatic acinar cells
and its activation is associated with pathological Ca2þ signals,
intracellular activation of digestive enzymes and cell injury, i.e.
the hallmarks of AP. Whereas the genetic deletion of Gpbar1
markedly reduced the severity of taurolithocholic acid 3-sulfate
(TLCS)-induced, but not caerulein-induced AP. Very recently,
Katona et al. provided solid evidence that specific BA might
be used as treatment option against biliary pancreatitis [23].
They showed that pre-treatment of pancreatic ducts with
ursodeoxycholate (UDCA) remarkably ameliorated the toxic
effects of UDCA. Chenodeoxycholate-induced intracellular
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death were completely prevented by UDCA, whereas the
activity of the epithelial acid–base transporters was preserved
in in vitro experiments. In addition, in vivo experiments
showed that oral administration of UDCA significantly reduced
the severity of CDCA-induced AP. Interestingly, UDCA had no
effect on the sustained Ca2þ elevation triggered by CDCA, rais-
ing the possibility of a direct mitochondrial protective effect,
which is yet to be determined. These observations nicely sup-
plement the previous results of Seyhun et al., who showed that
the endoplasmic reticulum (ER) chaperone tauroursodeoxy-
cholic acid inhibits the unfolded protein response (UPR) in
vitro [24] and in vivo [25]. This effect reduced the activation of
UPR components and reduced intracellular trypsin activation,
oedema formation and cell damage in pancreatic acinar cells.
(b) Ethanol and non-oxidative ethanol metabolites
The second most frequent form of pancreatitis is alcohol-
induced AP [26]. Whereas genetic factors seem to be involved
in the disease development [27], several studies investigated
the direct effects of ethanol and different ethanol metabolites
on the exocrine pancreas. Ethanol and its oxidative metabolite
acetaldehyde havemoderate effects on the [Ca2þ]i in pancreatic
acinar cells even in extremely high concentrations [28].
Whereas the non-oxidative ethanol metabolites (fatty acid
ethyl esters, FAEE) induced sustained [Ca2þ]i elevation and a
drop of cellular ATP leading to necrosis [28–30]. Importantly,
the breakdown of FAEE to fatty acids (FA) by intracellular
hydrolases significantly contribute to the toxic effects of
non-oxidative ethanol metabolites [30]. This fact has been
further emphasized in a recent elegant study by Huang et al.
[31]. They showed that the inhibition of oxidative ethanol
metabolism significantly enhance, whereas inhibition of non-
oxidative ethanol metabolism augment pancreatic damage in
an in vivo model of ethanol-fatty acid induced AP. On the
other hand pancreatic ductal cells respond to low to high con-
centrations of alcohol, likewise to BA. Yamamoto et al. showed
that 1 mM ethanol induces [Ca2þ]i, elevation and augments
fluid secretion,whereas high concentrationmoderately inhibits
the stimulated fluid secretion in secretin-stimulated guinea pig
pancreatic ducts [32]. Our group recently investigated the
effects of ethanol and ethanol metabolites in more detail [33].
We showed that alcohol and fatty acids inhibit fluid and
HCO 3 secretion, as well as cystic fibrosis transmembrane con-
ductance regulator (CFTR) activity, in pancreatic ductal cells.
Interestingly, in the case of FAEE only the inhibition of the
CFTR channel was observed in high concentrations [34]; how-
ever, the inhibition of HCO 3 secretion was not observed [33].
The remarkable inhibitory effects of alcohol and fatty acids
were mediated by sustained increase of intracellular Ca2þ,
inhibited adenosine 3’,5’-cyclic monophosphate and ATP pro-
duction and depolarization of DCm. We also showed that
ethanol reduced expression of CFTR via multiple pathways,
which in turn augmented the severity of experimental alco-
hol-induced AP in mice.
(c) Other stress factors
As demonstrated above, the two most common pathogenic
factors of AP—BA and ethanol—damage the exocrine pancreas
via Ca2þ toxicity and mitochondrial injury. Notably, these
cellular changes seem to be the key of AP pathogenesis since
a considerable number of studies showed that other stressfactors provoke the same alterations in Ca2þ signalling and
energy metabolism. Intrapancreatic trypsinogen activation is a
hallmark of AP pathogenesis and we showed earlier that tryp-
sin acting via PAR2 on the luminal membrane induces
intracellular Ca2þ elevation and inhibits the luminal acid/
base transporters in PDEC [35]. Moreover, the inhibitory
effect was abolished by BAPTA-AM preincubation, similarly
to the inhibitory effects of ethanol and fatty acids. Very recently,
Jin et al. investigated the pathomechanismof an iatrogen formof
AP, the post-ERCP pancreatitis [36]. Using sophisticated in vitro
and in vivo models, they showed that exposure of pancreatic
acinar cells to iohexol (a radiocontrast agent) triggered sustai-
ned intracellular Ca2þ elevation. The downstream activation
ofNF-kB andNFAT is completely abolished by the suppression
of theCa2þ signals.Moreover, they proved that the downstream
effects of Ca2þ were mediated by calcineurin since genetic,
or pharmacological inhibition of calcineurin prevented the
radiocontrast-induced damage. This interesting study further
underlines the central role ofpathophysiologicalCa2þ signalling
in the pathogenesis of AP regardless of the etiological factor.3. Sources of Ca2þ in pancreatic acinar and
ductal cells
(a) Ca2þ release from the endoplasmic reticulum
Agonist binding (Ach,ATP) toG-protein-coupled receptors acti-
vate phospholipase C b (PLCb) in pancreatic acinar and ductal
cells. The activated PLCb releases inositol trisphosphate (IP3) by
hydrolysing phosphatidylinositol 4,5-bisphosphate (PIP2) [37].
Under physiological conditions, the intracellular Ca2þ signals
have a strict spatio-temporal localization [38,39],mostly limiting
Ca2þ signals to the apical pole of the cells. As in other non-excit-
able cell types, this is ensured by two ATP-dependent pumps
that clear the cytosol fromthe freeCa2þ. The sarco/endoplasmic
reticulumCa2þ-ATPase (SERCA) pumps and the plasmamem-
brane Ca2þ-ATPase (PMCA) pumps move Ca2þ from the
cytosol to the ER and the extracellular space, respectively. This
activity restores basal intracellular Ca2þ levels and refills the
ER Ca2þ stores. In PDEC, the Ca2þ signalling is not character-
ized in such detail; however, the overall polarity of the ductal
cells including the ion channels and transporters, IP3 receptors
and mitochondria [17], suggest a very similarly regulated
Ca2þ signalling, like in acinar cells. Further studies are required
for the clarification of these questions.
(b) Extracellular Ca2þ influx
The complex role of extracellular Ca2þ influx to orchestrate non-
excitable cell functions has been established several decades ago
[40]; however, the molecular components participating in the
process remained unknown until 2005. Hoth et al. found that
agonist-mediated depletion of the intracellular Ca2þ stores
induced a Ca2þ selective sustained inwardly rectifying current,
whichwas termed ICRAC (calcium release-activated calciumcur-
rent) [41]. The real revolution of the field began by the discovery
of theERCa2þ sensor stromal interactionmolecule 1 (Stim1) [42]
and the plasma membrane Ca2þ channel Orai1 [43,44]. Briefly,
the process of store operated Ca2þ entry (SOCE) consist of the
following elements. In resting conditions the ER Ca2þ stores
are refilled and Stim1distributes in the ERmembrane.However
during physiological stimulation the ERCa2þ stores are quickly
depleted, which induces the dissociation of the bound Ca2þ
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change and translocation of Stim1 to defined ER-PM junctions,
termed as puncta formation [45]. This translocation is required
for the activation of the plasma membrane Ca2þ influx channel
Orai1,where the StimOrai1-activating region (SOAR) andpoly-
basic domains of Stim1 interact with different binding sites of
Orai1 that results in clustering and activation of the channel
[46]. In addition to Orai1, other possible Ca2þ entry channels
that seem to play a role in Stim1-mediated SOCE are the TRPC
channels [47,48]. These channels function as Ca2þ-permeable
non-selective cation channels mediating receptor evoked Ca2þ
influx in many cells [49]. SOCE have been investigated mostly
in acinar cells of various exocrine glands, as models of polarized
epithelial cells [50–52]. Interestingly, the role of SOCE in the
physiological functions of PDEC, especially in HCO 3 secretion
remained elusive. Kim et al. found that intracellular Ca2þ
elevation, caused by the activation of SOCE might play a role in
exocytosis in pancreatic ductal cells isolated from dogmain pan-
creatic duct [53,54]; however, they did not investigate HCO 3
secretion of PDEC, which therefore needs further investigation.04254. Mitochondrial Ca2þ handling and Ca2þ
overload of mitochondria
During physiological Ca2þ signalling, mitochondria takes up
Ca2þ, which has been shown to directly increase energy
output by enhancing the activity of tricarboxylic acid cycle
dehydrogenases and the ATP synthase [55]. The pioneer
work of Rizzuto et al. highlighted that the cytosolic Ca2þ sig-
nals propagate to the mitochondria [56] and a couple of years
later Csordas et al. found that ER membrane and the outer
mitochondrial membrane form a quasi-synaptic connection
[57] that is the structural bases of the Ca2þ hotspots [58].
Despite the functional characterization of the mitochondrial
Ca2þ signalling the molecular background of the process was
not known. In 2011, two groups independently identified the
mitochondrial Ca2þ uniporter (MCU), an inner mitochondrial
membrane protein that is responsible for the mitochondrial
Ca2þ uptake [59,60]. The Ca2þ efflux from the mitochondria
is mediated by the mitochondrial Naþ/Ca2þ exchanger
(NCLX) [61], thus the mitochondrial Ca2þ level is tightly
regulated under physiological conditions. However, patho-
physiological signals can lead mitochondrial injury, which
can activate both apoptosis and necrosis. The classical mito-
chondrial apoptotic pathway involves the outer membrane
permeabilization by Bax and Bak (two members of the
pro-death Bcl-2 family) that will allow apoptotic factors like
cytochrome c, Smac/DIABLO and apoptosis inducing factor
to be released from the intermembrane space into the cytosol,
leading to cell death by apoptosis [62]. On the other hand,
Ca2þ overload or increased reactive oxygen species (ROS) pro-
duction can cause the opening of mitochondrial permeability
transition pore (MPTP) that results in the loss of mitochondrial
inner membrane potential, uncoupling of the respiratory chain
with a consequent drop of mitochondrial ATP synthesis, and
increased permeability of the inner mitochondrial membrane
that eventually leads to mitochondrial swelling, rupture and
necrotic cell death [63,64]. Notably, recent studies lead to the
reconsideration of the role of MPTP in cellular physiology,
since it has been proved to be important in several physiologi-
cal processes such as energy metabolism [65], mitochondrial
Ca2þ efflux [66] and ROS signalling [67] as well. Themolecularidentity of MPTP is still a matter of investigation [68]. The his-
torical model of MPTP included the voltage-dependent anion
channel (VDAC) in the outer mitochondrial membrane, the
adenine nucleotide translocator (ANT) in the inner mitochon-
drial membrane, and CypD as its regulator in the matrix of
the mitochondria [69]. However recent intensive efforts
revealed newmolecules that might contribute to theMPTP for-
mation (reviewed in detail [68,70]). A growing number of
evidence suggest that VDAC is not very likely to contribute
to the MPTP formation. On the other hand, studies on ANT
suggest that it is not required for MPTP formation, but it regu-
lates MPTP activity [71]. CypD is an important regulator of
MPTP as supported by genetically modified mice [72] and
pharmacologic inhibition of CypD by cyclosporine A [73]. On
the other hand, several studies suggested that the activity of
F1F0 ATP synthase or the proapoptotic Bax/Bak proteins [74]
are required for proper MPTP function [75], whereas other pro-
teins, such asmitochondrial phosphate carrier,might impact the
pore opening indirectly [76]. At themoment the role ofMPTP in
the pathogenesis of AP is supported by limited, but still solid
evidence. Mukherjee et al. demonstrated that both genetic and
pharmacologic inhibitionofMPTPopening (using theCyclophi-
linD-deficientPpifgeneknockoutmice, or in vivo treatmentwith
cyclosporineAderivates, respectively) significantlyameliorated
pancreatic damage in different experimental APmodels inmice
[77]. Importantly MPTP blockade protected the pancreatic
acinar cells from necrosis whereas apoptosis was not affected,
which is in strong agreement of earlier studies [72].5. Novel therapeutic targets in acute pancreatitis
In pancreatic acinar cells, IP3-mediated Ca
2þ release from the
ER is an essential component of the physiological response to
agonist stimulation, but it could also contribute to the patho-
logical Ca2þ overload of the cells evoked by toxic factors that
induce AP (cerluien hyperstimulation, bile acids, or ethanol
and ethanol metabolites) [39]. Caffeine is a known inhibitor
of IP3Rs due to multiple actions that include the inhibition of
phospholipase C-mediated production of IP3 [78], antagonism
of IP3Rs [79] and direct binding to IP3Rs that reduce the
channels open-state probability [80]. Interestingly, coffee con-
sumption moderately reduces the risk of alcohol-associated
pancreatitis suggesting that the inhibitory effect of caffeine on
IP3-mediated Ca
2þ signalling may be protective in AP [81].
Based on these considerations Huang et al. recently studied
the effects of caffeine and its xanthinemetabolites on pancreatic
acinar IP3R-mediated Ca
2þ signalling and experimental AP
[82]. They found that caffeine and dimethylxanthines (but
not monomethylxanthines) blocks IP3-mediated Ca
2þ oscilla-
tions in response to uncaged IP3 or toxins, prevented
mitochondrial depolarization and necrotic cell death in vitro
and significantly impaired the severity of experimental AP
in three different models. These observations suggest that
caffeine, or its metabolites might be suitable starting points to
develop therapy for AP (figure 2).
As discussed above, store operated Ca2þ entry could be a
key component in the development of cellular Ca2þ overload.
Earlier Kim et al. showed that genetic [83] or pharmacological
inhibition (using the TRPC3-specific inhibitor pyrazole 3) [84]
of TRPC3 significantly reduce the sustained Ca2þ elevation in
pancreatic acinar cells evoked by cell stressors (bile acid or
fatty acid ethyl ester). In addition, it prevented the pathological
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Figure 2. Novel therapeutic targets in AP. Experimental studies from recent
years identified several proteins in cellular Ca2þ signaling machinery that
might be potential target molecules in AP treatment. Caffeine and dimethyl-
xanthines were shown to block IP3-mediated Ca
2þ release from the ER that
decreased the severity of AP in experimental models. Similarly, the inhibition
of the plasma membrane Ca2þ influx channels Orai1 and TRPC3 reduced the
severity of AP in animal models. Another treatment possibility might be the
inhibition of the MPTP opening, which improved the disease outcome in
rodents.
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intracellular trypsin activation and excessive actin depoly-
merization in vitro and the severity of pancreatitis in vivo.
Recently, Gerasimenko et al. demonstrated the pharmacological
inhibition of another Ca2þ entry channel Orai1 by a specific
inhibitor called GSK-7975Awhich prevents acinar cell necrosis
in vitro [85]. This important observationwas supported byWen
et al., who tested the effects of two specific Orai1 inhibitors
(GSK-7975A and CM_128) in isolated human and rodent
pancreatic acinar cells and in different experimental AP
models [86]. They showed that both Orai1 inhibitors prevented
the sustained Ca2þ elevation in vitro and significantly impaired
signs of pancreatic injury including pancreatic oedema,
inflammation and necrosis in all tested experimental models.
Mitochondrial permeability transition is a key feature of
cellular damage in many cell types and diseases (see above);
therefore, MPTP blockers are under detailed clinical investi-
gation in different studies. In a recent clinical study, the
efficacy and safety of TRO40303 (an MPTP inhibitor) have
been evaluated for the reduction of reperfusion injury inpatients undergoing revascularization for ST-elevation myo-
cardial infarction (MITOCARE study) [87]. This study did
not show any effect of TRO40303 in limiting reperfusion
injury of the ischaemic myocardium. In another recently
completed CIRCUS trial, the effects of i.v. administrated
cyclosporine have been evaluated on the clinical outcome of
patients with anterior STEMI [88]. Similarly to theMITOCARE
study, CIRCUS trial did not report any improvement in the
cyclosporine-treated patients. The reasons for the failure of
the studies might be explained by pharamological limitations
of the administrated compounds [89] that include low tissue
penetration due to the lack of collateral blood flow and high
metabolism of the compound in the blood. In addition,
MPTP blockers have been suggested to be beneficial in hepa-
titis C therapy, since they inhibited hepatitis C virus (HCV)
replication by preventing a cyclophilin-A induced cis–trans
isomerization in domain II of NS5A [90]. However, it was
not investigated in clinical trials further. Very recently,
Mukherjee et al. tested the effect of MPTP inhibition on the
severity of AP in rodent experimental AP models [77]. They
have shown that the inhibition of MPTP with pharmacological
compounds (two cyclosporine A derivate: DEB025 or
TRO40303), or genetic deletion of the Ppif gene (that encodes
cyclophylin D, a component of MPTP) significantly decreases
the severity of AP in different independent models. These
observations suggest that the MPTP inhibitionmight be poten-
tially beneficial in the AP therapy. Other indirect evidence for
this hypothesis has been provided by Judak et al., who showed
that the supplementation of cellular ATP in vitro diminished
the inhibitory effect of ethanol metabolites on the ion transport
activities in isolated guinea pig pancreatic ductal cells [34].
These results suggest that the restoration of the cellular
energy level can be beneficial in AP, which can prevent the
cellular dysfunction and cell damage.6. Closing remarks
Although there are several promising results and potential
drug targets that play a role in the pathogenesis of AP,
it remains a great challenge for researchers and clinicians.
A number of unanswered questions are waiting for answers.
Moreover, it will take several years to test the experimental
results on clinical patients as well. To be able take up these
challenges, clinicians and researchers should work closely
together in the future.
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